Global Tuberculosis Prevention and Treatment Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tuberculosis Prevention and Treatment Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tuberculosis Prevention and Treatment Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Tuberculosis Prevention and Treatment Vaccine Segment by Type

2.2.1 Immune Vaccine

2.2.2 Therapy Vaccine

2.3 Tuberculosis Prevention and Treatment Vaccine Sales by Type

2.3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Type (2017-2022)

2.4 Tuberculosis Prevention and Treatment Vaccine Segment by Application

2.4.1 Self-Procurement

2.4.2 UNICEF

2.4.3 Other

2.5 Tuberculosis Prevention and Treatment Vaccine Sales by Application

2.5.1 Global Tuberculosis Prevention and Treatment Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Application (2017-2022)

3 Global Tuberculosis Prevention and Treatment Vaccine by Company

3.1 Global Tuberculosis Prevention and Treatment Vaccine Breakdown Data by Company

3.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2020-2022)

3.2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Company

3.4 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Location Distribution

3.4.2 Players Tuberculosis Prevention and Treatment Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tuberculosis Prevention and Treatment Vaccine by Geographic Region

4.1 World Historic Tuberculosis Prevention and Treatment Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Geographic Region

4.2 World Historic Tuberculosis Prevention and Treatment Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Country/Region

4.3 Americas Tuberculosis Prevention and Treatment Vaccine Sales Growth

4.4 APAC Tuberculosis Prevention and Treatment Vaccine Sales Growth

4.5 Europe Tuberculosis Prevention and Treatment Vaccine Sales Growth

4.6 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Growth

5 Americas

5.1 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country

5.1.1 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022)

5.1.2 Americas Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022)

5.2 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Type

5.3 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region

6.1.1 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region (2017-2022)

6.1.2 APAC Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2017-2022)

6.2 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Type

6.3 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tuberculosis Prevention and Treatment Vaccine by Country

7.1.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022)

7.1.2 Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022)

7.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type

7.3 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine by Country

8.1.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type

8.3 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tuberculosis Prevention and Treatment Vaccine

10.3 Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine

10.4 Industry Chain Structure of Tuberculosis Prevention and Treatment Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tuberculosis Prevention and Treatment Vaccine Distributors

11.3 Tuberculosis Prevention and Treatment Vaccine Customer

12 World Forecast Review for Tuberculosis Prevention and Treatment Vaccine by Geographic Region

12.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region

12.1.1 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Region (2023-2028)

12.1.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Type

12.7 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Tuberculosis Prevention and Treatment Vaccine Product Offered

13.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Japan BCG Lab

13.2.1 Japan BCG Lab Company Information

13.2.2 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Offered

13.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Japan BCG Lab Main Business Overview

13.2.5 Japan BCG Lab Latest Developments

13.3 Serum Institute of India

13.3.1 Serum Institute of India Company Information

13.3.2 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Offered

13.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Serum Institute of India Main Business Overview

13.3.5 Serum Institute of India Latest Developments

13.4 AJ Vaccines

13.4.1 AJ Vaccines Company Information

13.4.2 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Offered

13.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AJ Vaccines Main Business Overview

13.4.5 AJ Vaccines Latest Developments

13.5 BioFarma

13.5.1 BioFarma Company Information

13.5.2 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Offered

13.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 BioFarma Main Business Overview

13.5.5 BioFarma Latest Developments

13.6 GreenSignal Bio Pharma

13.6.1 GreenSignal Bio Pharma Company Information

13.6.2 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Offered

13.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GreenSignal Bio Pharma Main Business Overview

13.6.5 GreenSignal Bio Pharma Latest Developments

13.7 China National Biotec

13.7.1 China National Biotec Company Information

13.7.2 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Offered

13.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 China National Biotec Main Business Overview

13.7.5 China National Biotec Latest Developments

13.8 Biomed Lublin

13.8.1 Biomed Lublin Company Information

13.8.2 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Offered

13.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Biomed Lublin Main Business Overview

13.8.5 Biomed Lublin Latest Developments

13.9 Taj Pharmaceuticals

13.9.1 Taj Pharmaceuticals Company Information

13.9.2 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Offered

13.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Taj Pharmaceuticals Main Business Overview

13.9.5 Taj Pharmaceuticals Latest Developments

13.10 Ataulpho de Paiva

13.10.1 Ataulpho de Paiva Company Information

13.10.2 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Offered

13.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Ataulpho de Paiva Main Business Overview

13.10.5 Ataulpho de Paiva Latest Developments

13.11 IVAC

13.11.1 IVAC Company Information

13.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Product Offered

13.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 IVAC Main Business Overview

13.11.5 IVAC Latest Developments

13.12 Queen Saovabha Mem. Inst

13.12.1 Queen Saovabha Mem. Inst Company Information

13.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Offered

13.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Queen Saovabha Mem. Inst Main Business Overview

13.12.5 Queen Saovabha Mem. Inst Latest Developments

13.13 Microgen

13.13.1 Microgen Company Information

13.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Product Offered

13.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Microgen Main Business Overview

13.13.5 Microgen Latest Developments

14 Research Findings and Conclusion

Table 1. Tuberculosis Prevention and Treatment Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tuberculosis Prevention and Treatment Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Immune Vaccine

Table 4. Major Players of Therapy Vaccine

Table 5. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2017-2022)

Table 13. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Tuberculosis Prevention and Treatment Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Producing Area Distribution and Sales Area

Table 21. Players Tuberculosis Prevention and Treatment Vaccine Products Offered

Table 22. Tuberculosis Prevention and Treatment Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Tuberculosis Prevention and Treatment Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Tuberculosis Prevention and Treatment Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Tuberculosis Prevention and Treatment Vaccine

Table 66. Key Market Challenges & Risks of Tuberculosis Prevention and Treatment Vaccine

Table 67. Key Industry Trends of Tuberculosis Prevention and Treatment Vaccine

Table 68. Tuberculosis Prevention and Treatment Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Tuberculosis Prevention and Treatment Vaccine Distributors List

Table 71. Tuberculosis Prevention and Treatment Vaccine Customer List

Table 72. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Forecast by Region

Table 74. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 94. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. Japan BCG Lab Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 99. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Japan BCG Lab Main Business

Table 101. Japan BCG Lab Latest Developments

Table 102. Serum Institute of India Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 104. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Serum Institute of India Main Business

Table 106. Serum Institute of India Latest Developments

Table 107. AJ Vaccines Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 109. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. AJ Vaccines Main Business

Table 111. AJ Vaccines Latest Developments

Table 112. BioFarma Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. BioFarma Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 114. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. BioFarma Main Business

Table 116. BioFarma Latest Developments

Table 117. GreenSignal Bio Pharma Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 119. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. GreenSignal Bio Pharma Main Business

Table 121. GreenSignal Bio Pharma Latest Developments

Table 122. China National Biotec Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 124. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. China National Biotec Main Business

Table 126. China National Biotec Latest Developments

Table 127. Biomed Lublin Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 129. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Biomed Lublin Main Business

Table 131. Biomed Lublin Latest Developments

Table 132. Taj Pharmaceuticals Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 134. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Taj Pharmaceuticals Main Business

Table 136. Taj Pharmaceuticals Latest Developments

Table 137. Ataulpho de Paiva Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 139. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Ataulpho de Paiva Main Business

Table 141. Ataulpho de Paiva Latest Developments

Table 142. IVAC Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 143. IVAC Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 144. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. IVAC Main Business

Table 146. IVAC Latest Developments

Table 147. Queen Saovabha Mem. Inst Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 148. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 149. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Queen Saovabha Mem. Inst Main Business

Table 151. Queen Saovabha Mem. Inst Latest Developments

Table 152. Microgen Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 153. Microgen Tuberculosis Prevention and Treatment Vaccine Product Offered

Table 154. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Microgen Main Business

Table 156. Microgen Latest Developments

List of Figures

Figure 1. Picture of Tuberculosis Prevention and Treatment Vaccine

Figure 2. Tuberculosis Prevention and Treatment Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tuberculosis Prevention and Treatment Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Immune Vaccine

Figure 10. Product Picture of Therapy Vaccine

Figure 11. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type in 2021

Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Tuberculosis Prevention and Treatment Vaccine Consumed in Self-Procurement

Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Market: Self-Procurement (2017-2022) & (K Units)

Figure 15. Tuberculosis Prevention and Treatment Vaccine Consumed in UNICEF

Figure 16. Global Tuberculosis Prevention and Treatment Vaccine Market: UNICEF (2017-2022) & (K Units)

Figure 17. Tuberculosis Prevention and Treatment Vaccine Consumed in Other

Figure 18. Global Tuberculosis Prevention and Treatment Vaccine Market: Other (2017-2022) & (K Units)

Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)

Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application in 2021

Figure 21. Tuberculosis Prevention and Treatment Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company in 2021

Figure 23. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2017-2022)

Figure 26. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Tuberculosis Prevention and Treatment Vaccine Sales 2017-2022 (K Units)

Figure 28. Americas Tuberculosis Prevention and Treatment Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Tuberculosis Prevention and Treatment Vaccine Sales 2017-2022 (K Units)

Figure 30. APAC Tuberculosis Prevention and Treatment Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Tuberculosis Prevention and Treatment Vaccine Sales 2017-2022 (K Units)

Figure 32. Europe Tuberculosis Prevention and Treatment Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2021

Figure 36. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2021

Figure 37. United States Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region in 2021

Figure 42. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Regions in 2021

Figure 43. China Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2021

Figure 50. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2021

Figure 51. Germany Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2021

Figure 58. Egypt Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Tuberculosis Prevention and Treatment Vaccine in 2021

Figure 64. Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine

Figure 65. Industry Chain Structure of Tuberculosis Prevention and Treatment Vaccine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles